Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

9 Apr 2020 10:21

RNS Number : 3649J
Mandarin Oriental International Ltd
09 April 2020
 

The following announcement has been issued to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

9th April 2020 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2020.

 

The Group's performance was severely impacted by the COVID-19 pandemic, resulting in an unaudited underlying loss of some US$40 million in the first quarter. A majority of the Group's hotels are now effectively closed and, while most hotels in Asia remain open, they are experiencing single digit percentage occupancy levels.

 

The Group has taken a number of actions to manage costs and preserve cash. These include the suspension of non-essential expenses and capital expenditure, significantly reducing payroll costs through unpaid leave, furloughing, substantial voluntary salary reductions at all levels and participation in government support measures wherever possible. The payroll measures have been taken proportionate to the seniority and means of colleagues. The Directors would like to express their deep gratitude for the continuing dedication and resolve of colleagues during these difficult times.

 

It is too early to forecast the duration of the impact of COVID-19 on the business but, as a result of the substantial reduction in revenue and management fees from the Group's hotels, the underlying loss in the second quarter is expected to be larger than in the first quarter.

 

In light of the exceptional circumstances, the Directors have withdrawn their recommendation of a final dividend in respect of the 2019 financial year and the relevant resolution seeking approval for the payment of the dividend will no longer be put to shareholders at the Company's AGM on 6th May 2020.

 

The Group's balance sheet and liquidity position both remain strong and will enable it to sustain the current low levels of business activity for an extended period of time. At 31st March 2020, net debt was US$363 million compared to net debt of US$300 million at the end of 2019. Gearing was 6% of adjusted shareholders' funds. During the quarter, the Group invested US$19 million in the restoration of Mandarin Oriental Ritz, Madrid.

 

At 31st March 2020, in addition to US$229 million of cash reserves, the Group also had US$207 million in available debt facilities that are committed for four years. The Group's facilities are not subject to any cash flow covenants.

 

While the Group's operations are currently being dramatically impacted by events associated with the COVID-19 pandemic, Mandarin Oriental remains a powerful brand that is well positioned to benefit over the long-term, when demand for luxury travel returns.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley (852) 2895 9288

Craig Beattie (852) 2895 9288

Brunswick Group Limited

David Ashton (852) 3512 5063

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCKKLBBBZLFBBV
Date   Source Headline
14th May 201812:08 pmRNSDirector/PDMR Shareholding
11th May 201810:12 amRNSDirector Declaration
9th May 20182:47 pmRNSDirectorate Change
9th May 20182:34 pmRNSNon-Routine Resolutions submitted via NSM
9th May 20182:19 pmRNSResult of AGM
9th May 201812:32 pmRNSInterim Management Statement
3rd May 201811:03 amRNSDirector/PDMR Shareholding
2nd May 201811:15 amRNSDirector/PDMR Shareholding
2nd May 201810:34 amRNSDividend
30th Apr 201810:54 amRNSTotal Voting Rights
25th Apr 201810:51 amRNSDirector/PDMR Shareholding
12th Apr 201810:49 amRNSAnnual Financial Report
29th Mar 201810:28 amRNSTotal Voting Rights
26th Mar 201810:34 amRNSBlock listing Interim Review
19th Mar 201811:11 amRNSDirector/PDMR Shareholding
14th Mar 20187:38 amRNSAdditional Listing
12th Mar 20189:16 amRNSDirector/PDMR Shareholding
8th Mar 20189:07 amRNS2017 PRELIMINARY ANNOUNCEMENT OF RESULTS
7th Feb 20189:14 amRNSNotice of 2017 Final Results
31st Jan 201810:33 amRNSTotal Voting Rights
16th Jan 201810:07 amRNSDirector/PDMR Shareholding
27th Dec 20179:39 amRNSDirector/PDMR Shareholding
21st Dec 201710:06 amRNSDirector/PDMR Shareholding
1st Dec 20179:58 amRNSDirector/PDMR Shareholding
30th Nov 20179:21 amRNSDirector/PDMR Shareholding
30th Nov 20179:17 amRNSTotal Voting Rights
31st Oct 20179:12 amRNSTotal Voting Rights
25th Oct 201711:15 amRNSDirector/PDMR Shareholding
4th Oct 201710:11 amRNSDividend
3rd Oct 201711:25 amRNSDirector/PDMR Shareholding
29th Sep 201711:09 amRNSDirector/PDMR Shareholding
27th Sep 20177:31 amRNSUpdate Review:Long-term Strategic Options for EXHK
25th Sep 201710:14 amRNSBlock listing Interim Review
15th Sep 201710:11 amRNSMO-Review of Long-term Strategic Options for EXHK
3rd Aug 201710:06 amRNSHalf Yearly Results
6th Jul 201710:15 amRNSNotice of 2017 Half-Yearly Results
5th Jun 20177:00 amRNSMO to Review Long-term Strategic Options for EXHK
3rd May 20172:13 pmRNSNon-Routine Resolutions submitted via NSM
3rd May 20172:01 pmRNSResult of AGM
3rd May 201712:35 pmRNSInterim Management Statement
28th Apr 201710:10 amRNSTotal Voting Rights
26th Apr 201710:40 amRNSDividend
5th Apr 201710:16 amRNSAnnual Financial Report
31st Mar 201710:42 amRNSTotal Voting Rights
27th Mar 201710:13 amRNSBlock listing Interim Review
27th Mar 201710:10 amRNSDirector/PDMR Shareholding
14th Mar 201711:04 amRNSDirector/PDMR Shareholding
3rd Mar 20178:06 amRNSAdditional Listing
2nd Mar 20179:06 amRNS2016 PRELIMINARY ANNOUNCEMENT OF RESULTS
1st Feb 20179:40 amRNSNotice of 2016 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.